SpringWorks Therapeutics Inc logo

SpringWorks Therapeutics Inc

NAS:SWTX (USA)  
$ 24.23 +0.435 (+1.83%) 10:13 AM EST
P/E:
At Loss
P/B:
3.36
Market Cap:
$ 1.52B
Enterprise V:
$ 1.02B
Volume:
27.96K
Avg Vol (2M):
543.16K
Volume:
27.96K
Market Cap $:
1.52B
PE Ratio:
At Loss
Avg Vol (2M):
543.16K
Enterprise Value $:
1.02B
PB Ratio:
3.36

Business Description

SpringWorks Therapeutics Inc logo
SpringWorks Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US85205L1070
Description
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
Name Current Vs Industry Vs History
Cash-To-Debt 62.67
Equity-to-Asset 0.87
Debt-to-Equity 0.02
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.43
9-Day RSI 27.01
14-Day RSI 32.67
6-1 Month Momentum % 11.49
12-1 Month Momentum % 15.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.55
Quick Ratio 11.55
Cash Ratio 11.37

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.2
Shareholder Yield % -0.08

Financials (Next Earnings Date:2023-11-03 Est.)

SWTX's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SWTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

SpringWorks Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -4.97
Beta 0.18
Volatility % 46.67
14-Day RSI 32.67
14-Day ATR ($) 1.367941
20-Day SMA ($) 26.532
12-1 Month Momentum % 15.52
52-Week Range ($) 21.04 - 34.16
Shares Outstanding (Mil) 62.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

SpringWorks Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

SpringWorks Therapeutics Inc Stock Events

Event Date Price($)
No Event Data

SpringWorks Therapeutics Inc Frequently Asked Questions

What is SpringWorks Therapeutics Inc(SWTX)'s stock price today?
The current price of SWTX is $24.23. The 52 week high of SWTX is $34.16 and 52 week low is $21.04.
When is next earnings date of SpringWorks Therapeutics Inc(SWTX)?
The next earnings date of SpringWorks Therapeutics Inc(SWTX) is 2023-11-03 Est..
Does SpringWorks Therapeutics Inc(SWTX) pay dividends? If so, how much?
SpringWorks Therapeutics Inc(SWTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1